Opinions
Shannon Saccocia, CIO, Boston Private
Teladoc Inc
TDOC-N
BUY ON WEAKNESS
Dec 31, 2021
We will likely see more growth in healthcare, namely in rural areas, so TDOC is positioned well. But this stock will be pressured in coming months, because of its high PE. If you enter any high-PE stock, buy just a partial position then add on volatility. TDOC is down 28% from its high.
$93.040
Stock price when the opinion was issued
Healthcare
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
DON'T BUY
He sold. Rough technically. A lot of money moved out of the pandemic names. Down 72%. Be careful, as he doesn't see the momentum changing right away. Need stronger earnings prints and better valuation for him. 5.5x price to sales, pretty expensive. Interest rates will be hard on those with strong revenue growth but no profit.
Healthcare
DON'T BUY
TDOC vs. QQQ vs. SOXX QQQ and SOXX, he has no idea where the market's going to be next month, next quarter, or this year. All he knows is that there's going to be a lot of volatility. So it's an environment of less investing, more trading. Have to be nimble, active. SOXX charts very well, it's the DOW modern day Transport Index, so you need to watch it. He was in TDOC a year ago, and backed away. Healthcare and biotech have had a difficult time.
Healthcare
TOP PICK
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Social media mentions are up 19% in the past 24h.
Healthcare